Lauren E. Strelec

556 total citations
11 papers, 81 citations indexed

About

Lauren E. Strelec is a scholar working on Pathology and Forensic Medicine, Oncology and Dermatology. According to data from OpenAlex, Lauren E. Strelec has authored 11 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 3 papers in Dermatology. Recurrent topics in Lauren E. Strelec's work include Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Lauren E. Strelec is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Lauren E. Strelec collaborates with scholars based in United States and Switzerland. Lauren E. Strelec's co-authors include Jakub Svoboda, Stephen J. Schuster, Anthony R. Mato, Sunita D. Nasta, Daniel J. Landsburg, Sarah Nagle, Steven M. Bair, Alison W. Loren, Edward A. Stadtmauer and David T. Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Lauren E. Strelec

11 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren E. Strelec United States 5 68 47 30 21 18 11 81
Gayane Tumyan Russia 5 75 1.1× 60 1.3× 56 1.9× 9 0.4× 22 1.2× 22 117
Zhiming Li China 7 65 1.0× 40 0.9× 22 0.7× 19 0.9× 27 1.5× 12 87
Catherine Thieblemont France 7 59 0.9× 56 1.2× 20 0.7× 15 0.7× 10 0.6× 23 97
Oscar Calzada United States 5 67 1.0× 55 1.2× 36 1.2× 8 0.4× 9 0.5× 8 91
Emily C. Ayers United States 5 33 0.5× 35 0.7× 17 0.6× 9 0.4× 13 0.7× 19 69
Sofya Kovalchuk Italy 6 67 1.0× 47 1.0× 19 0.6× 17 0.8× 20 1.1× 17 95
Gloria Margiotta Casaluci Italy 5 72 1.1× 60 1.3× 34 1.1× 15 0.7× 19 1.1× 11 99
Carlos Litovich United States 6 65 1.0× 80 1.7× 15 0.5× 12 0.6× 18 1.0× 12 99
Mara Andrés Spain 4 71 1.0× 57 1.2× 43 1.4× 23 1.1× 14 0.8× 5 109
Esther Hian Li Chan Singapore 6 43 0.6× 66 1.4× 17 0.6× 25 1.2× 28 1.6× 17 106

Countries citing papers authored by Lauren E. Strelec

Since Specialization
Citations

This map shows the geographic impact of Lauren E. Strelec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren E. Strelec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren E. Strelec more than expected).

Fields of papers citing papers by Lauren E. Strelec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren E. Strelec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren E. Strelec. The network helps show where Lauren E. Strelec may publish in the future.

Co-authorship network of co-authors of Lauren E. Strelec

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren E. Strelec. A scholar is included among the top collaborators of Lauren E. Strelec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren E. Strelec. Lauren E. Strelec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Shah, Nirav N., Anikó Szabó, Raya Saba, et al.. (2018). Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen. Clinical Lymphoma Myeloma & Leukemia. 19(2). 95–102. 9 indexed citations
2.
Farhan, Ahmed, Elise A. Chong, Stephen J. Schuster, et al.. (2018). Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study. Clinical Lymphoma Myeloma & Leukemia. 19(2). 109–115. 3 indexed citations
3.
4.
Bair, Steven M., Lauren E. Strelec, Sarah Nagle, et al.. (2017). Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American Journal of Hematology. 92(9). 879–884. 24 indexed citations
5.
Nagle, Sarah, Lauren E. Strelec, Alison W. Loren, et al.. (2017). Brentuximab-induced peripheral neuropathy: Risk factors and patient experiences.. Journal of Clinical Oncology. 35(5_suppl). 120–120. 4 indexed citations
6.
7.
Schuster, Stephen J., Jakub Svoboda, Sunita D. Nasta, et al.. (2016). Recovery of humoral immunity in patients with durable complete responses following chimeric antigen receptor modified t cells directed against CD19 (CTL019).. Journal of Clinical Oncology. 34(15_suppl). 7564–7564. 7 indexed citations
8.
Bair, Steven M., Lauren E. Strelec, Sunita D. Nasta, et al.. (2016). Outcomes in patients with relapsed/refractory Hodgkin lymphoma (RR-HL) with progression after autologous stem cell transplantation in the current era of novel therapeutics.. Journal of Clinical Oncology. 34(15_suppl). 2543–2543. 2 indexed citations
9.
Strelec, Lauren E., Sarah Nagle, Sunita D. Nasta, et al.. (2016). Patterns of Clinical Presentation in Patients with Classical Hodgkin Lymphoma and Impact on Prognosis. Blood. 128(22). 3002–3002. 1 indexed citations
10.
Svoboda, Jakub, Lauren E. Strelec, Sunita D. Nasta, et al.. (2015). Brentuximab Vedotin in Combination with Multi-Agent Chemotherapy Is Well Tolerated and Shows Promising Activity As Frontline Treatment for Primary Mediastinal B-Cell Lymphoma. Blood. 126(23). 2694–2694. 2 indexed citations
11.
Mato, Anthony R., Kenneth A. Foon, Tatyana Feldman, et al.. (2015). Reduced‐dose fludarabine, cyclophosphamide, and rituximab (FCR‐Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. American Journal of Hematology. 90(6). 487–492. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gayane Tumyan Breakdown of academic impact, for papers by Zhiming Li Breakdown of academic impact, for papers by Catherine Thieblemont Breakdown of academic impact, for papers by Oscar Calzada Breakdown of academic impact, for papers by Emily C. Ayers Breakdown of academic impact, for papers by Sofya Kovalchuk Breakdown of academic impact, for papers by Gloria Margiotta Casaluci Breakdown of academic impact, for papers by Carlos Litovich Breakdown of academic impact, for papers by Mara Andrés Breakdown of academic impact, for papers by Esther Hian Li Chan
Rankless by CCL
2026